DK0803249T3 - Cholesterolsænkende drikkeblandingssammensætninger - Google Patents

Cholesterolsænkende drikkeblandingssammensætninger

Info

Publication number
DK0803249T3
DK0803249T3 DK97302357T DK97302357T DK0803249T3 DK 0803249 T3 DK0803249 T3 DK 0803249T3 DK 97302357 T DK97302357 T DK 97302357T DK 97302357 T DK97302357 T DK 97302357T DK 0803249 T3 DK0803249 T3 DK 0803249T3
Authority
DK
Denmark
Prior art keywords
drink mix
cholesterol lowering
mix compositions
compositions
lowering drink
Prior art date
Application number
DK97302357T
Other languages
English (en)
Inventor
Sherry Lynn Diehl
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of DK0803249T3 publication Critical patent/DK0803249T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/25—Synthetic polymers, e.g. vinylic or acrylic polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK97302357T 1996-04-26 1997-04-07 Cholesterolsænkende drikkeblandingssammensætninger DK0803249T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/638,246 US5942550A (en) 1996-01-25 1996-04-26 Cholesterol lowering drink mix compositions

Publications (1)

Publication Number Publication Date
DK0803249T3 true DK0803249T3 (da) 2003-01-06

Family

ID=24559232

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97302357T DK0803249T3 (da) 1996-04-26 1997-04-07 Cholesterolsænkende drikkeblandingssammensætninger

Country Status (7)

Country Link
US (1) US5942550A (da)
EP (1) EP0803249B1 (da)
AT (1) ATE229321T1 (da)
DE (1) DE69717706T2 (da)
DK (1) DK0803249T3 (da)
ES (1) ES2184031T3 (da)
PT (1) PT803249E (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030091716A1 (en) * 2001-11-09 2003-05-15 Simpey Kuramoto Stable homogeneous drink composition including particulate cereal product
JP3930897B1 (ja) 2006-08-16 2007-06-13 太陽化学株式会社 粘度発現性を改良した増粘用組成物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1181003A (en) * 1967-03-20 1970-02-11 Mead Johnson & Co Therapeutic Compositions
US3974272A (en) * 1972-09-01 1976-08-10 Merck & Co., Inc. Palatable cholestyramine coacervate compositions
US4459280A (en) * 1982-07-23 1984-07-10 G. D. Searle & Co. Psyllium hydrophilic mucilloid composition
US4548806A (en) * 1982-07-23 1985-10-22 G. D. Searle & Co. Psyllium hydrophilic mucilloid composition
US4722847A (en) * 1986-05-07 1988-02-02 The Procter & Gamble Company Fruit juice beverages and juice concentrates nutritionally supplemented with calcium
US4895723A (en) * 1986-09-08 1990-01-23 Amer And Company Cholestyramine compositions and method for preparation thereof
CA1313135C (en) * 1987-02-09 1993-01-26 The Dow Chemical Company Cholestyramine composition and process for its preparation
DE320519T1 (de) * 1987-12-14 1989-10-26 The Boeing Co., Seattle, Wash. Cholestyraminzusammensetzungen und verfahren zu ihrer herstellung.
US5186965A (en) * 1990-06-14 1993-02-16 The Procter & Gamble Company Calcium citrate malate composition
US5380522A (en) * 1992-08-11 1995-01-10 Day; Charles E. Method for treatment of irritable bowel syndrome
US5422101A (en) * 1993-05-14 1995-06-06 The Procter & Gamble Company Cholesterol lowering drink mix compositions
US5612026A (en) * 1996-01-25 1997-03-18 The Procter & Gamble Company Cholesterol lowering drink mix compositons

Also Published As

Publication number Publication date
ES2184031T3 (es) 2003-04-01
DE69717706T2 (de) 2003-09-18
ATE229321T1 (de) 2002-12-15
US5942550A (en) 1999-08-24
DE69717706D1 (de) 2003-01-23
PT803249E (pt) 2003-04-30
EP0803249A2 (en) 1997-10-29
EP0803249B1 (en) 2002-12-11
EP0803249A3 (en) 1999-01-07

Similar Documents

Publication Publication Date Title
MY109880A (en) Substituted biphenylpyridones
DE69111480D1 (de) Gefüllter und abgedichteter, unabhängiger Mischbehälter.
GR3036622T3 (en) Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
IL111365A0 (en) (r)-5-carbamoyl -8-fluoro-3-n, n-disubstituted-amino-3, 4-dihydro-2h-1- benzopyrans
TW260704B (da)
DZ3165A1 (fr) Composition alimentaire ou pharmaceutique utiliseepour prevenir ou traiter l'hyperoxalurie.
ZA933273B (en) Sulfonylbenzyl-substituted benzo- and pyridopyridones
CA2160671A1 (en) Electrodepositable Compositions Containing Triorganotin Catalysts
EP0643038A3 (en) Polyfunctional cationic surfactants, their compositions, processes for their preparation and uses.
ITRM910151A0 (it) Perfezionamento nei containers, cassoni e simili auto-sollevabili e mobilizzabili manualmente.
DK0803249T3 (da) Cholesterolsænkende drikkeblandingssammensætninger
IL108997A0 (en) Heterotricyclically substituted phenyl-cyclohexane-carboxylic acid derivatives, their preparation and pharmaceutical compositions containing them
MY108877A (en) Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives.
TW276269B (da)
MX9201827A (es) Composicion suavizadora liquida.
HUT70614A (en) 3,4-dioxo-1-cyclobuten-1-yl-substituted (indolyl-alkyl)-pyridine- and -pyrimidine derivatives and antimigraine compositions containing them as active component
GB2284589B (en) Improvements in and relating to packaged fermented products, such as beer and the like
FI944162A0 (fi) Maustamattomia ratamojuomaseoskoostumuksia
EP0190860A3 (en) 6-chloro-3-methyl-1h-2,3,4,5-tetrahydro-3-benzazepine-n-oxide and medical compositions using it
WO1995022544A3 (de) Substituierte 1,3,8-triaza-spiro(4,5)-decan-4-on-derivate als vorstufen zur herstellung von pharmazeutika
DE69738917D1 (de) Flüssigkristallzusammensetzung, deren Herstellung und damit erzeugtes Flüssigkristallelement
AU4974493A (en) Dermatitis treatment compositions containing sulphur, salicylic acid and dimethylsulphone
DE3585679D1 (de) Hybridplasmide und diese enthaltende mikroorganismen.
DE3581641D1 (de) 1,4-thiazinabkoemmlinge, deren herstellung und diese enthaltende kardiotonische mittel.
ATE95546T1 (de) Polymerische zusammensetzungen und ihre anwendung fuer behaelterverschluesse.